Clever Leaves Holdings Inc. (CLVR) News
Filter CLVR News Items
CLVR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CLVR News Highlights
- For CLVR, its 30 day story count is now at 14.
- Over the past 27 days, the trend for CLVR's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- The most mentioned tickers in articles about CLVR are CBD, MG and THC.
Latest CLVR News From Around the Web
Below are the latest news stories about Clever Leaves Holdings Inc that investors may wish to consider to help them evaluate CLVR as an investment opportunity.
Clever Leaves Expands Partnership With Cansativa; Cansativa Raises Up to $15 Million in Financing Led by Casa VerdeClever Leaves enters three-year commercial supply agreement with German distributor and wholesaler to enhance access into medicinal cannabis marketBOCA RATON, Fla. and FRANKFURT, Germany, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced the expansion of its partnership with German cannabis distributor and wholesaler Ca |
Clever Leaves'' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm Partnership | BenzingaPharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ: |
Clever Leaves'' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm PartnershipPharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ: CLVR ) will soon be available for distribution by its partner in Germany , Ethypharm GmbH , a European specialty pharmaceutical company. Following a March 2021 supply agreement signed by the two companies providing Ethypharm access to Clever Leaves Holdings EU GMP certified cannabis extracts , the shipment includes two products: a 100 mg CBD with 3 mg THC per gram formulation and a 200 mg CBD with 6 mg THC per gram formulation . “As the largest medical cannabis market in Europe and one of the most … Full story available on Benzinga.com |
Clever Leaves Holdings Begins Sales of Cannabis Extracts in Germany Through Ethypharm PartnershipProducts imported and to be commercially available in German pharmacies Products imported and to be commercially available in German pharmacies |
Cannabis Movers & Shakers: Ascend Wellness, MedMen, Clever Leaves, Palo Santo, GoldCannAscend Wellness Promotes Frank Perullo To President Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH ) has promoted its co-founder and chief strategy officer, Frank Perullo, to president. At his new position, Perullo will be responsible for AWH''s day-to-day operations with the retail, sales and marketing as well as operations departments will report directly to Perullo going forward, in addition to his existing reports, the company said Monday. Abner Kurtin, founder and CEO of AWH will continue to lead the company and oversee Perullo, along with Dan Neville, chief financial officer, and Robin Debiase, chief people officer. “I can''t think of a better person to step into the President role than Frank, as we further develop our canopy, brand portfolio, and retail footprint in 20... |
Clever Leaves Expands Deal With Cannatrek In Australia Via $3.6M Sales Agreement To Include THC FlowerClever Leaves Holdings Inc. (NASDAQ: CLVR ) announced an expansion of its relationship with Australian medical cannabis company Cannatrek Ltd. by signing a two-year, take-or-pay basis supply agreement . The deal includes high-THC flower from Portugal, while expanding on its existing partnership for various 10% and 20% CBD oral solutions from Colombia announced in 2020. Licensed to distribute and sell to Australian medical cannabis patients, Cannatrek has been offering 10% and 20% CBD oral solutions supplied by Clever Leaves since 2020. Broadening the reach of both companies in Australia’s thriving market, Clever Leaves will now provide a strain of … Full story available on Benzinga.com |
Clever Leaves Expands Relationship With Cannatrek in Australia With a Two-Year $3.6M Sales AgreementThe agreement will now include high-THC Flower from Portugal facilities and will allow for the expansion of its oral solution supplyBOCA RATON, Fla. and MELBOURNE, Australia, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids today announced an expansion of its relationship with Australian medical cannabis company Cannatrek Ltd. (“Cannat |
Clever Leaves'' Q4 Revenue Up 25% YoY, Introduces 2022 Outlook & New CEOClever Leaves Holdings Inc. (NASDAQ: CLVR ) reported its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021, along with its 2022 outlook. Q4 2021 Financial Estimates vs. Same Year-Ago Quarter Revenue is expected to increase 25% to approximately $4.2 million compared to $3.3 million. Gross profit is expected to increase 5% to approximately $2.4 million compared to $2.3 million, with a gross margin of approximately 56.8% compared to 67.9%. Net loss is expected to range between approximately $17.1 million and $17.5 million compared to $0.9 million. Adjusted EBITDA (a non-GAAP number defined and reconciled herein) is expected to come in negative and range between approximately $(7.3) million and $(7.7) million compared to $(6.3) million. At ... |
Clever Leaves names Andres Fajardo as new CEO, stock down 5%(NASDAQ:CLVR)Clever Leaves Holdings (CLVR) has appointed director and president Andres Fajardo to succeed Kyle Detwiler as CEO, effective March 24, 2022.Until then, Detwiler will remain CEO and |
Clever Leaves Announces Preliminary Fourth Quarter and Full Year 2021 Results and Introduces 2022 OutlookPerformance Delivers on 2021 Outlook and Provides Solid Foundation for 2022 2022 Outlook and Strategic Growth Objectives Reflect Ramping Commercialization Opportunities Within Core Global Markets BOCA RATON, Fla., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, today announced its preliminary unaudited financial results for the fourt |